1. | | Recruiting | Avastin With or Without Erlotinib for Treatment of Metastatic Renal Cell Carcinoma Condition: Renal Cell Cancer |
2. | | Recruiting | Avastin/Placebo + Tarceva or Taxotere for Second-line Advanced Non-small Cell Lung Cancer Conditions: Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Adenocarcinoma; Carcinoma, Large Cell |
3. | | No longer recruiting | Chemotherapy With or Without Monoclonal Antibody in Treating Women With Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer |
4. | | No longer recruiting | Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Conditions: Stage IV rectal cancer; stage IV colon cancer |
5. | | No longer recruiting | Combination Chemotherapy With or Without Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer |
6. | | No longer recruiting | Efficacy and Safety Study of OSI-774 (Erlotinib) to Treat Advanced Lung Cancer Condition: Lung Cancer |
7. | | No longer recruiting | Efficacy and Safety Study of rhuFab V2 (Ranibizumab) to Treat Age-Related Macular Degeneration Condition: Age-Related Maculopathy |
8. | | Terminated | Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma Condition: Renal Cell Cancer |
9. | | No longer recruiting | Efficacy and Safety Study of Rituximab in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Condition: Rheumatoid Arthritis |
10. | | Recruiting | Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Condition: Carcinoma, Non-Small Cell Lung |
11. | | No longer recruiting | Erlotinib in Treating Women With Locally Advanced or Metastatic Breast Cancer Conditions: stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer |
12. | | Recruiting | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer Condition: Breast Cancer |
13. | | Recruiting | An Evaluation of the Safety and Efficacy of Ranibizumab in Patients with Age-Related Macular Degeneration (AMD) Condition: Macular Degeneration |
14. | | No longer recruiting | Extension Study of rhuFab V2 in Subjects with Neovascular Age-Related Macular Degeneration (AMD) Condition: Macular Degeneration |
15. | | Completed | Growth Hormone Use in Cystic Fibrosis - a Multicenter Study Condition: Cystic Fibrosis |
16. | | No longer recruiting | Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Conditions: Stage IV rectal cancer; stage IV colon cancer |
17. | | Completed | A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original study extended ONLY for patients previously enrolled on VEU 009) Condition: HIV Infections |
18. | | Completed | A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex Condition: HIV Infections |
19. | | Completed | A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients with HIV-Associated Immune Thrombocytopenic Purpura Conditions: Immune thrombocytopenic purpura ( ITP ); HIV Infections |
20. | | Completed | A Phase I Study of the Safety and Immunogenicity of rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers Condition: HIV Infections |
21. | | Completed | A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study extended ONLY for subjects who have previously received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover study) Condition: HIV Infections |
22. | | Completed | A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection Condition: HIV Infections |
23. | | Completed | A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex Condition: HIV Infections |
24. | | Completed | A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns Conditions: HIV Infections; Pregnancy |
25. | | Completed | A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection Condition: HIV Infections |
26. | | Completed | A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex Condition: HIV Infections |
27. | | Completed | A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex Condition: HIV Infections |
28. | | No longer recruiting | A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers Conditions: HIV Infections; HIV Seronegativity |
29. | | Completed | Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children Condition: HIV Infections |
30. | | Completed | A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3 Condition: HIV Infections |
31. | | Completed | A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults Condition: HIV Infections |
32. | | Completed | A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection Condition: HIV Infections |
33. | | Recruiting | RhVEGF (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers Condition: Diabetic Foot |
34. | | Recruiting | Rituximab/Fludarabine/Cyclophosphamide (FCR) versus Fludarabine/Cyclophosphamide (FC) Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) Condition: Chronic Lymphocytic Leukemia |
35. | | No longer recruiting | Safety & Efficacy Study of rhuFab V2 in Combination with Verteporfin for treatment of Age-related Macular Degeneration Condition: Age-Related Maculopathy |
36. | | Recruiting | Safety and Efficacy Study of Nutropin AQ to Treat Growth Restriction in Children with Cystic Fibrosis Condition: Cystic Fibrosis |
37. | | No longer recruiting | Safety and Efficacy Study of Omnitarg (Pertuzumab) to Treat Castration-Resistant Prostate Cancer Condition: Prostate Cancer |
38. | | No longer recruiting | Safety and Efficacy Study of rhuFAb V2 (Ranibizumab) to Treat Age-Related Macular Degeneration Condition: Age-Related Maculopathy |
39. | | Recruiting | Safety and Efficacy Study of Rituximab Compared with Placebo in Adults with Primary Progressive Multiple Sclerosis Condition: Primary Progressive Multiple Sclerosis |
40. | | Recruiting | A Safety and Efficacy Study of Xolair in Peanut Allergy Condition: Allergy |
41. | | Recruiting | A Safety Study of Escalating Doses of PRO70769 for Subjects with Moderate to Severe Rheumatoid Arthritis Receiving Stable Doses of Concomitant Methotrexate Condition: Rheumatoid Arthritis |
42. | | No longer recruiting | Safety Study of rhuMAb 2C4 to Treat Advanced Solid Tumors Condition: Neoplasms |
43. | | No longer recruiting | Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer Condition: Colorectal Cancer |
44. | | No longer recruiting | A study of Rituxan in the treatment of polyneuropathies associated with serum IgM autoantibodies Condition: Peripheral Neuropathy |
45. | | Recruiting | Study to evaluate the safety and effect of pertuzumab in patients with advanced non-small cell lung cancer, which has progressed after prior chemotherapy Condition: Non-small cell lung cancer |
46. | | No longer recruiting | A Study to Evaluate the Safety and Effect of Pertuzumab on Cancerous Lesions in Women with Advanced, Refractory or Recurrent Ovarian Cancer Condition: Ovarian Cancer |
47. | | Recruiting | Treatment of HER2-Positive Metastatic Breast Cancer with Herceptin and Bevacizumab (antibodies against HER2 and VEGF) Condition: Breast Cancer |
48. | | Suspended | Trial of Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer in Previously Treated Patients Conditions: Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell |